Medetomidine and Xylazine – Current Situation in Canada

Name: Medetomidine and Xylazine – Current Situation in Canada
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Health Canada’s Drug Analysis Service (DAS) operates laboratories across Canada that analyze suspected illicit drugs samples submitted by law enforcement agencies and public health partners. The aim of this info sheet is to offer key insights on medetomidine and xylazine based on samples submitted to DAS laboratories.

Publisher: Health Canada
Resources: 2
Updated: 2026-08-06

Resources

Medetomidine and Xylazine – Current Situation in Canada PDF
Medetomidine and Xylazine – Current Situation in Canada PDF

Related open data

Health Canada